Navigation Links
Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
Date:10/14/2010

t limited to, quotations from management in this press release, statements regarding strategic and operation plans, and statements regarding the development or commercialization of therapies.  Forward-looking statements are based on current beliefs and expectations and are subject to inherent risks and uncertainties. You are cautioned not to place undue reliance on forward-looking statements. Although Talecris believes that the forward-looking statements contained in this press release are reasonable, there is no assurance that expectations will be fulfilled. The following factors, among others, could cause actual results to differ materially from those expressed or implied in forward-looking statements: possible U.S. legislation or regulatory action affecting, among other things, the U.S. healthcare system, pharmaceutical pricing and reimbursement, including Medicaid and Medicare; our ability to procure adequate quantities of plasma and other materials which are acceptable for use in our manufacturing processes from our own plasma collection centers or from third-party vendors; our ability to maintain compliance with government regulations and licenses, including those related to plasma collection, production and marketing; our ability to identify growth opportunities for existing products and our ability to identify and develop new product candidates through our research and development activities; and the timing of, and our ability to, obtain and/or maintain regulatory approvals for new product candidates, the rate and degree of market acceptance, and the clinical utility of our products.  Additional information about factors that could affect the business and financial results of Talecris is contained in its final Prospectus filed pursuant to Rule 424(b)(1) with the Securities and Exchange Commission on October 1, 2009. Talecris undertakes no duty to update any forward-looking statement.


'/>"/>
SOURCE Talecris Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Talecris Biotherapeutics to Report Third Quarter 2010 Financial Results
2. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
3. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
4. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
5. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
6. NASDAQ Trading for Oxygen Biotherapeutics, Inc. Shares to Begin January 15, 2010
7. Oxygen Biotherapeutics, Inc. Announces Approval for NASDAQ Listing
8. Oxygen Biotherapeutics, Inc. Expands Board of Directors
9. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
10. Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
11. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... its 2014 second quarter financial results on Tuesday, August ... Company management will host a live audio webcast immediately ... to provide a business and financial update and discuss ... may access the live audio webcast via the Investors ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 22, 2014 Legislation backed by the ... Local Pharmacies Act of 2014") championing so-called "any ... undermine the availability of lower cost preferred pharmacy ... over the next 10 years, according to new ... Pharmaceutical Care Management Association (PCMA). The ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... 2011 West Pharmaceutical Services, Inc. (NYSE: WST ... investor conferences. Management will attend the 9th Annual ... NY.  Management will present an overview of West,s business and ... Management will also attend the UBS 2011 Global ...
... 2011 Prescription monitoring laboratory and clinical partner ... its Safe Use Treatment Monitoring Solution™. Consistent with ... compliant with the FDA,s Opioid Risk and Evaluation ... for controlled substances.  The program aims to support ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2
(Date:7/22/2014)... 22, 2014 As one alternative to ... to buy can now reduce or in some cases ... released its cosmetic buying guide to help buyers find ... http://cherrynews.com/best-nourishing-eye-serum . , This guide is meant for both ... different under eye circles that can appear. While some ...
(Date:7/22/2014)... Africa (PRWEB) July 23, 2014 It all ... in an attempt to find common ground. Willem de Liefde ... the crossroads of their lives or careers. , Willem wrote ... deeper and look beyond the surface of things. It is ... future, driven by care and commitment. , This book represents ...
(Date:7/22/2014)... Obtaining a bachelor’s degree in nursing ... have hands-on medical experience. The School of Nursing at ... the launch of an accelerated nursing degree program that ... program, the UNCG Veterans Access Program (VAP), will start ... With some prior college credit, veterans who are RNs ...
(Date:7/22/2014)... Dr. Dental is excited to announce the redesign ... in mind, one of the main differences from the old ... navigation very easy. Dr. Dental is renowned for having exceptional ... dentist affordable, convenient and fun, and the new website mirrors ... appointment scheduling system right on the home page where a ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's leading ... an insurance veteran with more than 15 years of ... based in the company's Chicago office. , UBA Board ... chose to accept this important, strategic position with UBA. ... challenges facing UBA and its Partners as we move ...
Breaking Medicine News(10 mins):Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5
... eggs to deteriorate in quality with age, and can that ... egg -- out of a stash of roughly one million ... be influenced to pick a "good" quality egg rather than ... much on the mind of fertility researcher Teresa Woodruff. Woodruff, ...
... a key protein might reap rewards for people ... (HealthDay News) -- Researchers have uncovered cellular proteins that ... according to a new study. , The findings, ... new treatments for a range of human diseases that ...
... WASHINGTON, June 19 Most seniors -,regardless ... Medicare or Medicare,Advantage - oppose cutting the ... payment fix and believe cuts to Medicare ... a new survey finds., Power Point ...
... Protections for Poor Beneficiaries, SAN FRANCISCO, June ... federal court today in the Medicare Part D ... has agreed to make,significant changes to its administration ... approved by the judge, the agreement will,make it ...
... DALLAS, June 19 Federal Reserve chairman Ben Bernanke,s,comments ... health care,system is one of the biggest challenges facing ... care costs will rise nearly 10 percent this,year, lend ... emphasis on,prevention and wellness, according to U.S. Preventive Medicine, ...
... Better Health offers members access to 75 generic drugs at no cost ... ... Independence Blue Cross (IBC),will waive copays and coinsurance on 75 generic drugs ... a member incentive,program designed to help our members become more actively involved ...
Cached Medicine News:Health News:New photo 'op' for ovaries may solve some mysteries of infertility 2Health News:Autoimmune Disease Treatment May Not Dampen Immune System 2Health News:Autoimmune Disease Treatment May Not Dampen Immune System 3Health News:Autoimmune Disease Treatment May Not Dampen Immune System 4Health News:Seniors Oppose Cutting Medicare Advantage to Fund Physician Payment Fix 2Health News:Bush Administration Settles Nationwide Class Action in Medicare Prescription Drug Case 2Health News:Bush Administration Settles Nationwide Class Action in Medicare Prescription Drug Case 3Health News:U.S. Preventive Medicine Views Bernanke's Comments as Strong Support for Prevention and Wellness Programs 2Health News:Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 2Health News:Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 3Health News:Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions 4
... Rail clamp with self-adjusting adaptability to ... permits complete versatility of angling at the ... The 3/D Swinger permits it to be ... With the Iron Intern®, a simple adjustment ...
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view...
Inquire...
Inquire...
Medicine Products: